RxCell
Healthcare & Life Sciences
Recent Finacing
Equity
Recent Raise
$4.6M
RxCell is a biotech company developing cellular therapies using iPSC-derived cells to treat age-related diseases, particularly focusing on restoring vision in patients with Age-related Macular Degeneration (AMD).
Focus Areas
Biotech
Cellular Therapeutics
Age-related Diseases
iPSC-derived Photoreceptors
RPE Cells
Vision Restoration
Investors
